Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
A 1-month LillyDirect self-pay supply costs $149 for 0.8 mg, $199 for 2.5 mg, $299 for 5.5 mg and 9 mg, and $349 for 14.5 mg and 17.2 mg and eligible commercially insured patients can pay as little as $25 per month with a savings card
Stretching the interval, taking the lowest dose every other week instead of weekly
Eat slowly, stop when comfortably full, and avoid pushing through fullness
Gastrointestinal Safety Assessment of GLP-1 Receptor Agonists in the US: A Real-World Adverse Events Analysis from the FAERS Database
Hydration behavior of L-proline in the presence of mono, bis, tris-(2-hydroxyethyl) ammonium acetate protic ionic liquids: thermophysical properties
The Numbers You Need to Know On December 20, 2024, the FDA approved Zepbound as the first-ever drug treatment for moderate-to-severe obstructive sleep apnea in adults with obesity In the approval trials, apnea events fell by roughly 27 to 30 per hour on tirzepatide versus about 5 to 6 per hour on placebo over 52 weeks Participants lost approximately 18 to 20% of their body weight on the drug, and the FDA notes the apnea improvement is likely related to that weight reduction What Is Zepbound (Tirzepatide)
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
